Clinical trial
A Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients With Open-Angle Glaucoma or Ocular Hypertension
NCT02636946 is registered in ClinicalTrials.gov with Allergan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients With Open-Angle Glaucoma or Ocular Hypertension
- Lead sponsor
- Allergan
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- February 24, 2016
- Completion date
- January 26, 2021
- Enrollment
- 144 (actual)
- Sites
- 33
Conditions
As the registry lists them; a condition with its own page is linked.
glaucoma, open-angle ocular hypertension